Michael Enxing has been appointed as vice president and chief commercial officer of Vertiflex.
Enxing will be responsible for leading the company’s sales, marketing, health economics/reimbursement and professional education strategies, related to the launch of the Superion indirect decompression system for the treatment of lumbar spinal stenosis.
Enxing has worked in product commercialisation in the medical device, spinal and chronic pain fields for over 20 years. Most recently, he served as vice president of Sales at Nevro. Prior to this, he served as vice president of Sales and Marketing for Vertos Medical, and has held various executive positions at Cardiovascular Systems; Advanced Neuromodulation Systems; Stryker; and Tecnol Medical Products.
Michael is a graduate of Iowa State University, Ames, USA with a bachelor of science in Communications and focus in Business Administration.